NWQ Investment Management Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$41.1M Sell
153,129
-7,935
-5% -$2.14M 1.86% 9
2020
Q2
$42.4K Sell
161,064
-11,863
-7% -$3.16M 1.42% 9
2020
Q1
$39.3M Buy
+172,927
New +$47.1M 1.58% 11
2017
Q4
Sell
-6,400
Closed -$1.22M 200
2017
Q3
$1.22M Sell
6,400
-1,600
-20% -$305K 0.01% 174
2017
Q2
$1.5M Hold
8,000
0.02% 169
2017
Q1
$1.32M Sell
8,000
-1,000
-11% -$159K 0.02% 167
2016
Q4
$1.29M Buy
+9,000
New +$1.21M 0.02% 183

Other funds holding ELV

NWQ Investment Management Company's ELV Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Elevance Health (ELV) stake by 4.9% in Q3 2020, selling an estimated $2.14M and leaving 153,129 shares worth $41.1M. The position accounts for 1.86% of the portfolio, ranked #9.

NWQ Investment Management Company first reported a position in ELV in Q4 2016 and has held it in 7 quarters since. 1,095 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • NWQ Investment Management Company held 153,129 shares of Elevance Health worth $41.1M as of Q3 2020.
  • NWQ Investment Management Company sold 7,935 Elevance Health shares in Q3 2020, an estimated $2.14M.
  • Elevance Health made up 1.86% of NWQ Investment Management Company's portfolio in Q3 2020, its #9 holding.
  • NWQ Investment Management Company first reported a position in Elevance Health in Q4 2016 and has held it in 7 quarters since.
  • 1,095 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.